Kevin Richetin

This study shows that astrocytic secretome enhances adult hippocampal neurogenesis and spatial memory in healthy and disease models.

The paper examines reduced SV2A levels in AD brain tissue and extracellular vesicles, linking them to amyloid-β, tau, and synaptic markers.

The paper identifies distinct proteomic signatures in brain-derived extracellular vesicles from 3R and 4R tauopathies, linking them to disease-specific cellular and molecular changes.

This study identifies PEA116, an astrocyte-derived peptide that enhances adult hippocampal neurogenesis and stress resilience by promoting aNSC proliferation through ERK2 phosphorylation.

This study examines how extracellular tau aggregates affect mitochondrial function in neurons and astrocytes, revealing cell-specific responses and potential therapeutic targets.

This study shows JCPyV infects astrocytes, dysregulates cell biology, and affects excreted vesicles, providing insights into PML pathogenesis.

This study shows that tau-containing extracellular vesicles from neurons transfer tau to astrocytes, disrupting their mitochondrial function, with 3R tau being more damaging than 4R tau.